Study designs comparative

PSAs estimate that the frequency of reactor damage cover about two orders of magnitude from about lE-5/y to lE-3/y. This variation is attributable to plant design, construction, and operation, to site characteristics, scope of the PSAs, and methods and analytical assumptions. Such comprehensive studies of comparable chemical process plants do not exist. 

The latest tw o-phase flow research and design studies have broadened the interpretation of some of the earlier flow patterns and refined some design accuracy for selected situations. The method presented here serves as a fundamental reference source for further studies. It is suggested that the designer compare several design concept results and interpret which best encompasses the design problem under consideration. Some of the latest references are included in the Reference Section. No one reference has a solution to all two-phase flow problems. 

The data on the epidemiology of anaphylaxis are widely varying estimates on the frequency of this condition. The findings are based on diverse study designs and are often not comparable. A clear conclusion from the data published so far is difficult. One major reason is that there is no universal consensus regarding the definition of anaphylaxis. The International Classification Codes (ICD) recording anaphylaxis are imprecise and do not properly reflect the epidemiological needs. 

Reference Study design (location) Drugs compared (n)... 

Finally, trials can follow parallel or crossover study designs. In a parallel trial, patients are assigned to a therapy that they remain on, and they are compared with patients in alternate therapy groups. In a crossover trial, patients switch or change therapy assignments during the course of the trial. 

Biopharmaceutical issues to be addressed will include a discussion of the pharmaceutical development process as it relates to in vivo and in vitro performance and the general approach taken concerning bioavailability, bioequivalence, and in vitro dissolution profiles. There should be a comparative analysis of relevant studies—objectives, study design, conduct, outcome, and data analyses. The effects of formulation changes (including different strengths of product and... 

Year Authors Ref. Comparative agent Duration of (study design) treatment Evaluation criteria Overall assessment... 

---